Memorial Sloan Kettering (MSK) Cancer Center's lymphoma specialist, Dr. Palomba, provides an in-depth look at how CAR T-cell therapy is evolving to offer hope for more patients battling hematologic malignancies. Read more: https://health.economictimes.indiatimes.com/news/industry/on-site-car-t-cell-production-cutting-costs-and-time-with-rapid-manufacturing/118386449